SNO 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences
University of Alabama at Birmingham at SNO 2026
Nov 12–15, 2026 Philadelphia, PA ~3k attendees Website
University of Alabama at Birmingham brings 14 presentations to SNO 2026 in Philadelphia. Its program leans toward experimental therapeutics, including epigenetic drug combinations for diffuse midline glioma and ependymoma. Humanized mouse models and immune-modulating agents for glioblastoma also feature.
| Organization | SNO 2026 Attendance |
|---|---|
University of Alabama at Birmingham Birmingham, AL | |
A public research university with a major academic medical center and research programs in cancer and neuro-oncology. | Talk Thu Nov 12 11:05am–1:50pm Talk Fri Nov 13 11:48–11:51am Talk Fri Nov 13 12:09–12:12pm Talk Fri Nov 13 12:18–12:21pm Session Fri Nov 13 5–6pm Poster Fri Nov 13 7:30–9:30pm Poster Fri Nov 13 7:30–9:30pm Poster Fri Nov 13 7:30–9:30pm Poster Fri Nov 13 7:30–9:30pm Poster Fri Nov 13 7:30–9:30pm Poster Fri Nov 13 7:30–9:30pm Talk Sat Nov 14 11:04–11:09am Talk Sat Nov 14 11:39–11:42am |
Find decision makers at University of Alabama at Birmingham
Tell us what you sell and we’ll find the people at University of Alabama at Birmingham most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the Society for Neuro-Oncology. Submit a correction